Found 0 matching trials
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder PHASE3 The primary objective of the study is to demonstrate the efficacy of SPD489...
Show More Location
Radiant Research, Inc.
Learn More & Join Trial
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC PHASE1 The goal of this clinical trial is to evaluate the safety and tolerability ...
Show More Location
Liverpool Cancer Therapy Centre
Learn More & Join Trial
Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors NA Cancer therapy-related cardiac dysfunction (CTRCD) has become a major cause...
Show More Location
The First Affiliated Hospital of Xinjiang Medical University
Learn More & Join Trial
Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment NA The goal of this study is to determine whether transcranial magnetic stimul...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial
Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis PHASE1 Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tiss...
Show More Location
Stony Brook University Hospital /ID# 222653
Learn More & Join Trial
Effectiveness of Acceptance Commitment Therapy or Micro Breaks in Patients with Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis NA Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a distinct d...
Show More Location
University Hospital of Zurich
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder PHASE2 The purpose of this study is to gain initial safety, tolerability, pharmaco...
Show More Learn More & Join Trial
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors PHASE1 This is an open-label, phase 1/1b study evaluating the safety, tolerability...
Show More Learn More & Join Trial
A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors PHASE1 This is a 2-part trial: Part A (Dose Escalation) is designed to establish t...
Show More Status
Active Not Recruiting
Location
California Clinical Trials Medical Group (CCTMG)
Learn More & Join Trial
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) PHASE2 Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Show More Location
City of Hope /ID# 261468
Learn More & Join Trial